Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
GTE
|
Jim Evans
VP, Corporate Services |
BUY
Grant, award, or other acquisition
|
Direct | 4,059 Added 1.55% |
$934
$0.23 p/Share
|
Oct 05
2020 |
|
LUNG
|
Staffan Lindstrand
Director |
BUY
Conversion of derivative security
|
Indirect | 1,133,728 Added 23.5% |
-
|
Oct 05
2020 |
|
LUNG
|
Dana G Mead Jr. |
BUY
Open market or private purchase
|
Direct | 26,315 Added 50.0% |
$499,985
$19.0 p/Share
|
Oct 05
2020 |
|
LUNG
|
Dana G Mead Jr. |
BUY
Conversion of derivative security
|
Indirect | 1,524,109 Added 21.97% |
-
|
Oct 05
2020 |
|
LUNG
|
Georgia Melenikiotou |
BUY
Open market or private purchase
|
Direct | 26,315 Added 50.0% |
$499,985
$19.0 p/Share
|
Oct 05
2020 |
|
LUNG
|
Richard Ferrari |
BUY
Conversion of derivative security
|
Direct | 3,030 Added 50.0% |
-
|
Oct 05
2020 |
|
LUNG
|
Richard Ferrari |
BUY
Conversion of derivative security
|
Indirect | 1,221,489 Added 25.79% |
-
|
Oct 05
2020 |
|
LUNG
|
Richard Ferrari |
BUY
Open market or private purchase
|
Direct | 13,157 Added 44.84% |
$249,983
$19.0 p/Share
|
Oct 05
2020 |
|
LUNG
|
Daniel P Florin |
BUY
Open market or private purchase
|
Indirect | 15,789 Added 50.0% |
$299,991
$19.0 p/Share
|
Oct 05
2020 |
|
QTRX
|
E Kevin Hrusovsky
Executive Chairman |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 0.19% |
$67,800
$33.9 p/Share
|
Oct 05
2020 |
|
HBNC
|
Craig M Dwight
Director |
BUY
Acquisition or disposition by will or laws
|
Direct | 885 Added 0.37% |
-
|
Oct 05
2020 |
|
IMXI
|
Robert Lisy
CEO, President & Chairman |
SELL
Open market or private sale
|
Indirect | 125,000 Reduced 10.75% |
$1,595,000
$12.76 p/Share
|
Oct 05
2020 |
|
IMXI
|
John Rincon
Director |
SELL
Open market or private sale
|
Indirect | 300,000 Reduced 29.84% |
$3,828,000
$12.76 p/Share
|
Oct 05
2020 |
|
GSHD
|
Robyn Mary Elizabeth Jones
Director |
SELL
Open market or private sale
|
Direct | 27,242 Reduced 5.24% |
$2,308,487
$84.74 p/Share
|
Oct 05
2020 |
|
PRGS
|
Rainer Gawlick
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 3.05% |
$37,770
$37.77 p/Share
|
Oct 05
2020 |
|
LXP
|
Richard Frary |
BUY
Grant, award, or other acquisition
|
Direct | 2,250 Added 2.2% |
$24,997
$11.11 p/Share
|
Oct 05
2020 |
|
LXP
|
Lawrence L Gray
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,250 Added 3.94% |
$24,997
$11.11 p/Share
|
Oct 05
2020 |
|
LXP
|
Jamie Handwerker
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,250 Added 4.25% |
$24,997
$11.11 p/Share
|
Oct 05
2020 |
|
LXP
|
Claire A Koeneman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,250 Added 3.27% |
$24,997
$11.11 p/Share
|
Oct 05
2020 |
|
LXP
|
Howard Stewart Roth
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,250 Added 5.66% |
$24,997
$11.11 p/Share
|
Oct 05
2020 |
|
CYTK
|
Santo J Costa
Director |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$450,000
$30.0 p/Share
|
Oct 05
2020 |
|
CYTK
|
Santo J Costa
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 15,000 Added 50.0% |
$141,750
$9.45 p/Share
|
Oct 05
2020 |
|
CYTK
|
Ching Jaw
SVP Finance & CFO |
SELL
Open market or private sale
|
Direct | 27,500 Reduced 27.28% |
$825,000
$30.0 p/Share
|
Oct 05
2020 |
|
CYTK
|
Ching Jaw
SVP Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 27,500 Added 23.75% |
$247,775
$9.01 p/Share
|
Oct 05
2020 |
|
CYTK
|
Edward M. Md Kaye
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 100.0% |
$600,000
$30.0 p/Share
|
Oct 05
2020 |
|
CYTK
|
Edward M. Md Kaye
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 50.0% |
$152,200
$7.61 p/Share
|
Oct 05
2020 |
|
CYTK
|
John T Henderson
Director |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 76.94% |
$87,000
$29.0 p/Share
|
Oct 05
2020 |
|
CYTK
|
John T Henderson
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 3,000 Added 55.57% |
$38,880
$12.96 p/Share
|
Oct 05
2020 |
|
CYTK
|
Sandford D Smith
Director |
SELL
Open market or private sale
|
Direct | 5,936 Reduced 100.0% |
$178,080
$30.0 p/Share
|
Oct 05
2020 |
|
CYTK
|
Sandford D Smith
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,936 Added 50.0% |
$43,748
$7.37 p/Share
|
Oct 05
2020 |
|
LUNG
|
Boston Scientific Corp
> 10% Shareholder |
BUY
Conversion of derivative security
|
Direct | 5,987,965 Added 50.0% |
-
|
Oct 05
2020 |
|
D
|
Thomas F Farrell Ii
Executive Chairman |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 4.76% |
$4,004,000
$80.08 p/Share
|
Oct 05
2020 |
|
FDX
|
Donald F Colleran
President/CEO FedEx Express |
SELL
Open market or private sale
|
Direct | 6,845 Reduced 14.91% |
$1,781,753
$260.3 p/Share
|
Oct 05
2020 |
|
FDX
|
Donald F Colleran
President/CEO FedEx Express |
BUY
Exercise of conversion of derivative security
|
Direct | 6,845 Added 12.98% |
$583,536
$85.25 p/Share
|
Oct 05
2020 |
|
GOOG
|
John L Hennessy |
SELL
Open market or private sale
|
Indirect | 60 Reduced 0.1% |
$88,397
$1473.29 p/Share
|
Oct 05
2020 |
|
RWLK
|
Jeff Dykan
Director |
SELL
Payment of exercise price or tax liability
|
Indirect | 840 Reduced 1.15% |
$907
$1.08 p/Share
|
Oct 05
2020 |
|
MRAM
|
Sanjeev Aggarwal
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct | 697 Reduced 3.02% |
$3,938
$5.65 p/Share
|
Oct 05
2020 |
|
GDOT
|
Jason Bibelheimer
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 9,813 Reduced 11.52% |
$602,911
$61.44 p/Share
|
Oct 05
2020 |
|
TVTX
|
Peter Heerma
CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 2,188 Reduced 4.91% |
$42,338
$19.35 p/Share
|
Oct 05
2020 |
|
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 0.05% |
$3,777,150
$251.81 p/Share
|
Oct 05
2020 |
|
FREQ
|
Christopher R. Loose
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 6.26% |
$146,800
$18.35 p/Share
|
Oct 05
2020 |
|
NTIP
|
Steven D. Heinemann
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 4,604 Reduced 0.21% |
$12,661
$2.75 p/Share
|
Oct 05
2020 |
|
PCF
|
Phillip Goldstein
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 5.24% |
$41,150
$8.23 p/Share
|
Oct 05
2020 |
|
EVER
|
Seth Birnbaum
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 5,078 Added 1.15% |
$34,937
$6.88 p/Share
|
Oct 05
2020 |
|
MORF
|
Robert E Farrell Jr
SVP Finance and CAO |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 2.75% |
$53,120
$26.56 p/Share
|
Oct 05
2020 |
|
MORF
|
Alexey Lugovskoy
Chief Development Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.97% |
$26,500
$26.5 p/Share
|
Oct 05
2020 |
|
RVMD
|
Barbara Weber |
SELL
Open market or private sale
|
Direct | 7,196 Reduced 79.92% |
$260,279
$36.17 p/Share
|
Oct 05
2020 |
|
RVMD
|
Barbara Weber |
BUY
Exercise of conversion of derivative security
|
Direct | 7,196 Added 44.42% |
$8,060
$1.12 p/Share
|
Oct 05
2020 |
|
LILA
|
Charles H R Bracken
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,799 Added 15.37% |
-
|
Oct 05
2020 |
|
LILA
|
Miranda Curtis
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 765 Added 4.77% |
-
|
Oct 05
2020 |